title: Expression of lumican in hidroacanthoma simplex and clonal-type seborrheic keratosis as a potent differential diagnostic marker.
abstract: Lumican, a member of the small leucine-rich proteoglycan family, regulates the assembly and diameter of collagen fibers in the extracellular matrix of various tissues. The lumican expression correlates with pathological conditions and the growth and metastasis of various malignancies. In cutaneous neoplasms, the lumican expression is lower in advanced-stage malignant melanomas that invade the dermis than in early-stage melanomas. Furthermore, we have recently reported that the expression pattern of lumican is different from that of actinic keratosis and the Bowen disease. Lumican is positive in the poroid cells of intraepidermal sweat ducts; therefore, we examined the expression patterns of lumican in acanthotic-type seborrheic keratosis and Pinkus-type poroma followed by clonal-type seborrheic keratosis and hidroacanthoma simplex. The neoplastic cells of acanthotic-type seborrheic keratosis exhibited positive immunostaining in only 1 of 31 cases (3.23%), whereas the poroid cells of Pinkus-type poroma exhibited positive immunoreactivity in 26 of 28 patients (92.8%). In the hidroacanthoma simplex cases, lumican was expressed in poroid cells forming intraepidermal nests in 22 of 28 patients (78.6%), whereas the neoplastic cells in most cases of clonal-type seborrheic keratosis were negative for lumican. In some seborrheic keratosis cases that were positive for lumican in neoplastic cells, lumican was observed in squamoid cells but not in basaloid cells. Therefore, it is necessary to evaluate the immunoreactivity of lumican in seborrheic keratosis and in basaloid cells. These findings suggest that lumican is a potent differential diagnostic marker that distinguishes hidroacanthoma simplex from clonal-type seborrheic keratosis.
authors: Departments of *Dermatology, and †Pathology and Integrative Oncological Pathology, Nippon Medical School, Bunkyo-ku, Tokyo, Japan.
authors: Ryoko
authors: R
authors: Takayama
authors: Shin-Ichi
authors: S
authors: Ansai
authors: Toshiyuki
authors: T
authors: Ishiwata
authors: Tetsushi
authors: T
authors: Yamamoto
authors: Yoko
authors: Y
authors: Matsuda
authors: Zenya
authors: Z
authors: Naito
authors: Seiji
authors: S
authors: Kawana
mesh_terms: D049309:Acanthoma / Q000737:chemistry* / Q000473:pathology; D014408:Biomarkers, Tumor / Q000032:analysis*; D001706:Biopsy; D011508:Chondroitin Sulfate Proteoglycans / Q000032:analysis*; D003937:Diagnosis, Differential; D006801:Humans; D007150:Immunohistochemistry; D007632:Keratan Sulfate / Q000032:analysis*; D017492:Keratosis, Seborrheic / Q000378:metabolism* / Q000473:pathology; D000071234:Lumican; D057091:Poroma / Q000737:chemistry* / Q000473:pathology; D011237:Predictive Value of Tests; D012878:Skin Neoplasms / Q000737:chemistry* / Q000473:pathology; D013544:Sweat Gland Neoplasms / Q000737:chemistry* / Q000473:pathology
chemical_list: D014408:Biomarkers, Tumor; D011508:Chondroitin Sulfate Proteoglycans; C000604306:LUM protein, human; D000071234:Lumican; D007632:Keratan Sulfate